Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions

Journal of General Virology

Volumn 78, Issue 12, 1997, Pages 3195-3206

  Taylor, Geraldine ^a   Thomas, Lewis H ^a   Furze, Julie M ^a   Cook, Roy S ^a   Wyld, Sara G ^a   Lerch, Robert ^b,c   Hardy, Richard ^b   Wertz, Gail W ^b  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY; VACCINE; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CATTLE; CONTROLLED STUDY; INTRATRACHEAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYSTEM; VACCINATION; VACCINIA VIRUS; VIRUS RECOMBINANT; VIRUS RESISTANCE;

ANIMALIA; BOS TAURUS; BOVINAE; BOVINE RESPIRATORY SYNCYTIAL VIRUS; HUMAN RESPIRATORY SYNCYTIAL VIRUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; SYNCYTIAL VIRUS; VACCINIA; VACCINIA VIRUS;

EID: 0030838277     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-12-3195     Document Type: Article

References (35)

1. Aherne, W., Bird, T., Court, S. D. M., Gardner, P. S. & McQuillin, J. (1970). Pathological changes in virus infections of the lower respiratory tract in children. Journal of Clinical Pathology 23, 7-18.
2. Alcami, A. & Smith, G. L. (1995). Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. Journal of Virology 69, 4633-4639.
3. Alwan, W. H. & Openshaw, P. J. M. (1993). Distinct patterns of T-and B-cell immunity to respiratory syncytial virus induced by individual viral proteins. Vaccine 11, 431-437.
4. Alwan, W. H., Kozlowska, W. J. & Openshaw, P. J. M. (1994). Distinct types of lung disease caused by functional subsets of antiviral T cells. Journal of Experimental Medicine 179, 81-89.
5. Amann, V. L., Lerch, R. A., Anderson, K. & Wertz, G. W. (1992). Bovine respiratory syncytial virus nucleocapsid protein: mRNA sequence analysis and expression from recombinant vaccinia virus vectors. Journal of General Virology 73, 999-1003.
6. Ball, L. A., Young, K. K. Y., Anderson, K., Collins, P. L. & Wertz, G. W. (1986). Expression of the major glycoprotein G of human respiratory syncytial virus from recombinant vaccinia virus vectors. Proceedings of the National Academy of Sciences, USA 83, 246-250.
7. Collins, P. L., Purcell, R. H., London, W. T., Lawrence, L. A., Chanock, R. M. & Murphy, B. R. (1990). Evaluation in chimpanzees of vaccinia virus recombinants that express the surface glycoproteins of human respiratory syncytial virus. Vaccine 8, 164-168.
8. Connors, M., Collins, P. L., Firestone, C.-Y. & Murphy, B. R. (1991). Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by the M2 and N proteins is relatively short-lived. Journal of Virology 65, 1634-1637.
9. Connors, M., Collins, P. L., Firestone, C.-Y., Sotnokov, A. V., Waitze, A., Davis, A. R., Hung, P. P., Chanock, R. M. & Murphy, B. R. (1992a). Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia-RSV recombinants or RSV. Vaccine 10, 475-484.
10. Connors, M., Kulkarni, A. B., Collins, P. L., Firestone, C.-Y., Holmes, K. L., Morse, H. C. & Murphy, B. R. (1992b). Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8 + T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies. Journal of Virology 66, 1277-1281.
11. Crowe, J. E., Collins, P. L., London, W. T., Chanock, R. M. & Murphy, B. R. (1993). A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV. Vaccine 11, 1395-1404.
12. Furze, J., Wertz, G., Lerch, R. & Taylor, G. (1994). Antigenic heterogeneity of the attachment protein of bovine respiratory syncytial virus. Journal of General Virology 75, 363-370.
13. Furze, J. M., Roberts, S. R., Wertz, G. W. & Taylor, G. (1997). Antigenically distinct G glycoproteins of BRSV strains share a high degree of genetic homogeneity. Virology 231, 48-58.
14. Gaddum, R. M., Cook, R. S., Wyld, S. G., Lopez, J. A., Bustos, R., Melero, J. A. & Taylor, G. (1996). Mutant forms of the F protein of human respiratory syncytial (RS) virus induce a cytotoxic T lymphocyte response but not a neutralizing antibody response and only transient resistance to RS virus infection. Journal of General Virology 77, 1239-1248.
15. Kennedy, H. E., Jones, B. V., Tucker, E. M., Ford, N. J., Clarke, S. W., Furze, J., Thomas, L. H. & Stott, E. J. (1992). Production and characterization of bovine monoclonal antibodies to respiratory syncytial virus. Journal of General Virology 69, 3023-3032.
16. Kim, H. W., Canchola, J. G., Brandt, C. D., Pyles, G., Chanock, R. M., Jensen, K. & Parrott, R. M. (1969). Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. American Journal of Epidemiology 89, 422-434.
17. Lerch, R. A., Anderson, K. & Wertz, G. W. (1990). Nucleotide sequence analysis and expression from recombinant vectors demonstrate that the attachment protein G of bovine respiratory syncytial virus is distinct from that of human respiratory syncytial virus. Journal of Virology 64, 5559-5569.
18. Lerch, R. A., Anderson, K., Amann, V. L. & Wertz, G. W. (1991). Nucleotide sequence analysis of the bovine respiratory syncytial virus fusion protein mRNA and expression from a recombinant vaccinia virus. Virology 181, 118-131.
19. Olmsted, R. A., Elango, N., Prince, G. A., Murphy, B. R., Johnson, P. R., Moss, B., Chanock, R. M. & Collins, P. L. (1986). Expression of the glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: Comparison of the individual contributions of the F and G glycoproteins to host immunity. Proceedings of the National Academy of Sciences, USA 83, 7462-7466.
20. Olmsted, R. A., Buller, R. M. L., Murphy, B. R., Beeler, J. A. & Collins, P. L. (1988). Evaluation in nonhuman primates of the safety, immunogenicity, and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virus. Vaccine 6, 205-210.
21. Openshaw, P. J. M., Pemberton, R. M., Ball, L. A., Wertz, G. W. & Askonas, B. A. (1988). Helper T cell recognition of respiratory syncytial virus in mice. Journal of General Virology 69, 305-312.
22. Openshaw, P. J. M., Clarke, S. L. & Record, F. M. (1992). Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. International Immunology 4, 493-500.
23. Sharma, A. K., Woldehiwet, Z., Walrevans, K. & Letteson, J. (1996). Immune responses of lambs to the fusion (F) glycoprotein of bovine respiratory syncytial virus expressed on insect cells with a recombinant baculovirus. Vaccine 14, 773-779.
24. Small, P. A., Smith, G. L. & Moss, B. (1985). Intranasal vaccination with a recombinant vaccinia virus containing influenza hemagglutinin prevents both influenza virus pneumonia and nasal infection: intradermal vaccination prevents only viral pneumonia. In Vaccine 85, pp. 175-176. Edited by R. A. Lerner, R. M. Chanock & F. Brown. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
25. Stott, E. J. & Taylor, G. (1985). Respiratory syncytial virus. Brief review. Archives of Virology 84, 1-52.
26. Stott, E. J., Thomas, L. H., Taylor, G., Collins, A. P., Jebbett, J. & Crouch, S. (1984). A comparison of three vaccines against respiratory syncytial virus in calves. Journal of Hygiene, Cambridge 93, 251-261.
27. Stott, E. J., Taylor, G., Ball, L. A., Anderson, K., Young, K. K. Y., King, A. M. Q. & Wertz, G. W. (1987). Immune and histological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. Journal of Virology 61, 3855-3861.
28. Takao, S.-I., Kiyotani, K., Sagaguchi, T., Fujii, Y., Seno, M. & Yoshida, T. (1997). Protection of mice from respiratory Sendai virus infection by recombinant vaccinia viruses. Journal of Virology 71, 832-838.
29. Taylor, G., Stott, E. J., Bew, M., Fernie, B. F., Cote, P. J., Collins, A. P., Hughes, M. & Jebbett, J. (1984). Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52, 137-142.
30. Taylor, G., Stott, E. J. & Thomas, L. H. (1987). Lymphocyte transformation response of calves to respiratory syncytial virus. Journal of Medical Virology 22, 333-344.
31. Taylor, G., Stott, E. J., Furze, J., Ford, J. & Sopp, P. (1992). Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies. Journal of General Virology 73, 2217-2223.
32. Taylor, G., Thomas, L. H., Wyld, S. G., Furze, J., Sopp, P. & Howard, C. J. (1995). Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves. Journal of Virology 69, 6658-6664.
33. Thomas, L. H., Gourlay, R. N., Stott, E. J., Howard, C. J. & Bridger, J. C. (1982). A search for new microorganisms in calf pneumonia by the inoculation of gnotobiotic calves. Research in Veterinary Science 33, 170-182.
34. Thomas, L. H., Stott, E. J., Collins, A. P. & Jebbett, J. (1984). Experimental pneumonia in gnotobiotic calves produced by respiratory syncytial virus. British Journal of Experimental Pathology 65, 19-28.
35. Wertz, G. W., Stott, E. J., Young, K. K. Y., Anderson, K. & Ball, L. A. (1987). Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated mice. Journal of Virology 61, 293-301.